RANCHO CORDOVA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (“Cesca”) (Nasdaq:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has priced a best efforts registered public offering of up to an aggregate of 900,000 shares of the Company’s common stock at a price to the public of $3.00 per share. The offering is expected to close on or about December 1, 2017, subject to the satisfaction of customary closing conditions.
Dawson James Securities, Inc. is acting as exclusive placement agent for the offering.
The aggregate gross proceeds of the offering are anticipated to be up to approximately $2.7 million. After deducting the placement agent’s commission and other estimated offering expenses payable by the Company, the net proceeds to the Company are anticipated to be up to approximately $2.3 million. Cesca intends to use the net proceeds from this offering for general corporate purposes, including working capital.
The shares are being offered pursuant to an effective shelf registration statement on Form S-3, as amended (File No. 333-212314), that was previously filed with the Securities and Exchange Commission (SEC) and declared effective on August 1, 2016. The securities may be offered only by means of a prospectus. The prospectus has been filed with the SEC and is available on the SEC’s website located at http://www.sec.gov. The preliminary prospectus supplement related to the offering will be available on the SEC’s website located at http://www.sec.gov and may also be obtained from Dawson James Securities, Inc., Attention: Prospectus Department, 1 North Federal Highway, 5th Floor, Boca Raton, FL 33432, [email protected], or toll free at 866.928.0928.
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor may there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
